Literature DB >> 583489

[Comparative study of the absolute bioavailability of four oral digoxin preparations (author's transl)].

N Rietbrock, R G Alken, W Ebert.   

Abstract

In a randomized cross over study on 19 normal subjects the absolute bioavailability of four oral digoxin preparations (Digacin containing a silica gel matrix as preparation A and three other commercial digoxin tablet preparations, B, C and D) were investigated applying digoxin in a daily dose of 0.25 mg for 10 consecutive days. On day 8, 9 and 10, the serum digoxin concentration and the amount of digoxin excreted with 24-h urine were measured radioimmunologically. After i.v. administration the mean serum digoxin concentration amounted to 0.58 ng/ml. With oral administration preparation A achieved the highest concentration (0.51 ng/ml) and preparation C the lowest (0.42 ng/ml). Accordingly, after i.v. administration 118 microgram digoxin were excreted with the 24-h urine and 95 microgram after the oral preparation A and 73 microgram after preparation C, respectively. From the serum concentrations and the amount excreted with the urine the absolute bioavailability was calculated: 88.0 and 80.4%, respectively, for preparation A, 82.5 and 67.2% for preparation B, 72.7 and 61.8% for preparation C, 76.2 and 67.3% for preparation D.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 583489

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

1.  On the pharmacokinetics of pengitoxin and its cardioactive derivative 16-acetyl-gitoxin.

Authors:  K O Haustein; R G Alken; H J Lach; U Becker; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals.

Authors:  V W Steinijans; E Diletti
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  On the pharmacokinetics of 16-acetyl-gitoxin and its bioavailability from pengitoxin-containing tablet formulations.

Authors:  K O Haustein
Journal:  J Pharmacokinet Biopharm       Date:  1986-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.